SENSEX
NIFTY
GOLD
USD/INR

Weather

image 39    C

Top News News

The Hindu

Top News / The Hindu

details

Why Semaglutide is an inflection point for Indias generics sector?

More than a supply chain issue and missing the first mover status, Semaglutide episode has rather exposed systemic chinks and could prove costly for Indias pharmaceutical industry, which supplies about 20% of the worlds generic medicines by volume.

15 Jul 2026 6:41 am